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For many years, the traditional treatment of ovarian cysts has been laparotomy. This
approach is characterized, however, by elevated morbidity given that the majority of
these cysts are very often benign. The main problem regarding the laparoscopic ap-
proach to the ovarian cyst is the risk of treating an ovarian cancer. As a consequence,
there can be a worsening of prognosis, due to spillage at the time of laparoscopic
surgery.
According to the literature, the incidence of ovarian carcinoma among patients
who have undergone operative laparoscopy for adnexal masses varies from 0.1% to
4.2%.1–8 Canis et al.6 reported 19 cases of ovarian tumors out of 819 adnexal masses
in 757 patients. The 19 ovarian tumors (2.32%) were classified as (n = 7) ovarian car-
cinomas and low malignant potential tumors (n = 12). If we consider the incidence
of these tumors in relation to age, 1.8% were found in women under 50 and 7.6%
were found in women over 50 years of age.
In a retrospective study, Maiman et al.2 reported a total of 42 cases of malignancy
after laparoscopic treatment of ovarian masses. However, only 12% of the physicians
interviewed had used tumor markers, and only 40% had requested an intraoperative
frozen section. Moreover, four of the most accepted benign characteristics of cysts,
that is, diameter less than 8 cm, cystic neoplasm, unilaterality, and uniloculariety,
were present in 31% of the cases.
Some retrospective studies9–13 on the problem of spillage have reported that sur-
gical rupture of the capsule in stage I epithelial ovarian cancer has an adverse influ-
ence on survival prognosis. However, other retrospective studies have reported that
surgical rupture of a malignant cyst is not a negative prognostic factor, at multivari-
ate analysis. In fact, some authors affirm that prognosis is not influenced at all if the
patient is immediately treated.14–16
We would like to stress that the majority of ovarian cysts (87%) are benign17 and
are therefore eligible for endoscopic treatment. Following strict guidelines (echo-
graphic criteria of benignity: unilaterality, uniloculariety, absence of septa > 3 mm
and intracystic vegetation, and pure borders; CA 125 levels < 35 IU/ml; benign lap-
aroscopic appearance of cyst and the peritoneal cavity) and using cautious manage-
ment, laparoscopic treatment of ovarian cysts can be reliable and safe.
On the other hand, Canis et al.6 reported on two malignant tumors that had been
macroscopically suspicious and were treated as benign masses. The false negative
diagnoses (1.5%) were due to inadequate sampling. Thus, Canis suggested that the
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complete cyst, and not only a fragment or small bioptic sample, be submitted for in-
traoperative histologic examination. Chapron et al.18 treated 26 patients with sus-
pected signs of ovarian malignancy using laparoscopic adnexectomy with an
endoscopic bag. The results of the intraoperative histological examination for all
these patients were benign. The definitive histological results confirmed the frozen
section findings. Using the same strategy, we have been able to avoid laparotomy,
especially in postmenopausal patients, who, at ultrasound, present with complex ad-
nexal masses. Laparotomy should not be considered a complication when managing
suspicious adnexal masses. Immediate vertical laparotomy remains the gold stan-
dard for macroscopically suspicious masses. Although this approach is acceptable in
postmenopausal patients,6 laparoscopic adnexectomy of suspicious masses at ultra-
sound is not acceptable in young patients. The false positive rate of diagnosis of ma-
lignancy at ultrasound is still very high.
One pressing question must be asked: Can we distinguish a benign tumor from a
malignant one? Appropriate patient selection for laparoscopic ovarian surgery re-
quires information on the characteristics of the cyst. This can be obtained by ultra-
sound examination. One of the most important advances in gynecological ultrasound
diagnosis has been the introduction of transvaginal sonography, which gives a good
image of the pelvic organs given the closeness of the ultrasound transducer to the
genital organs.
The protocol at our departement for the diagnosis and management of ovarian
persistent cysts is based on a multimodal approach using clinical examination, case
history, transabdominal and transvaginal ultrasonography, transvaginal color Dop-
pler, and serum values of CA125 and other markers (CA19.9, CA15.3, CA72.4,
CEA, αFP, βhCG).
The echographic criteria for distinguishing benign cysts are the following: unilat-
eral mass, unilocular cyst, absence of both septa > 3 mm and intracystic vegetations,
and pure borders.19,20 However, using Sassone’s score, which considers 9 as the cut-
off point used to distinguish malignant from nonmalignant cysts,21 several complex
benign cysts, such as dermoid cysts, could be considered malignant.
If the above-mentioned criteria are respected, such as those evaluated by a trans-
vaginal probe, and the dosage of CA125 employed is < 35 IU/ml,8 the probability of
finding a benign formation is very high. Some authors have noted that by using these
specific ultrasonographic criteria, the negative predictive value has been 96%19; in
post-menopausal women, the same values range from 95% to 100%.22,23 When an
ovarian mass is sonographically defined as a unilocular and nonechogenic cyst, the
negative predictive value reported has been between 90% and 95%.19,24 Other au-
thors have reported 100% specificity by using a combination of the clinical exami-
nation, CA125 dosage < 35 IU/ml, and transvaginal ultrasound.25,26
In a prospective study that included 1769 asymptomatic postmenopausal patients,
Conway27 found ovarian cysts in 116 patients at ultrasound. The prevalence was
6.6%. Out of the 116 patients, 27 (23.28%) had simple cysts that disappeared spon-
taneously, 60 (50.48%) had persistent cysts, and 20 (17.24%) were lost to follow-up
study. Eighteen out of the 60 women (26.09%) with persistent simple ovarian cysts
underwent surgery. No malignant ovarian aspects were identified. Simple ovarian
cysts are more common in postmenopausal women than had been previously be-
lieved. However, given that such cysts are unlikely to be or become malignant, con-
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servative treatment can be followed. In fact, Kroon et al.28 reported that 12 out of 32
(37.5%) cysts had spontaneously disappeared in a group of postmenopausal women
with small, simple anechoic ovarian cysts.
Recently, the use of transvaginal color Doppler (TV-CDS) has allowed us to in-
crease our knowledge on the state of neovascularization of the ovarian cyst wall.29,30
It has become clear that this technique is a valuable tool for differentiating benign
from malignant ovarian tumors.30–33
A low pulsatility index (PI) or resistance index (RI) indicates a low impedance to
blood flow in the distal vasculature, as seen in neoplasias; a high PI or RI (associated
with absent intratumoral neovascularization with color Doppler) is said to exclude
ovarian cancer. According to the literature, the percentage of true positives varies
from 80% to 100%, with a false positivity of 0%–20%. Fleischer33 compared trans-
vaginal color-Doppler ultrasonography with histologic findings in 126 ovarian mass-
es. He reported a sensitivity level of 92%, a specificity level of 86%, a PPV of 86%,
and a NPV of 98%. Furthermore, in 3 out of the 126 cases, the CD was highly sug-
gestive of ovarian cancer, although the morphologic findings had not been suspi-
cious. The mean and SD of the PI values in the benign group (1.4 ± 0.6) showed a
statistically significant difference when compared to the malignant groups (0.6 ±
0.4) (p = 0.04). However, there was overlap in the range of PI values of the benign
(0.8 to 2.0) and malignant groups (0.3 to 1.2).
According to Zanetta,34 color Doppler is more accurate than conventional ultra-
sound and CA125 in discriminating malignancies from benign tumors. The best uses
of this technique seem to be the gathering of ulterior preoperative information con-
cerning masses with uncertain sonographic characteristics, and that of allowing bet-
ter timing and tailoring of surgery.
CA125 is an antigen, identified by OC125 monoclonal antibody, found in cells
cultured from patients with serous papillary ovarian carcinoma. Eighty percent of
patients with known epithelial ovarian cancer respond positively to CA125 assay. It
is correlated with tumor volume, but the percentage can be high in benign epithelial
cysts such as endometrioma, adenomyosis, myoma, and PID. In the presence of cer-
tain factors such as a pelvic mass, however, a serum level of CA125 > 50 IU/ml and
postmenopausal age, the probability of a malignant neoplasia is from 80 to 90%.
Furthermore, during laparoscopy we can obtain information by observing both
the cyst and the peritoneal cavity. An aspiration of the peritoneal fluid sample, a
careful examination of the cystic ovary, and a complete inspection of the pelvic peri-
toneum, the contralateral ovary, and the omentum can be performed using laparos-
copy. Endoscopic bags can be used to remove the cyst or the whole ovary without
spillage. Thus, intraoperative histological examination can be performed. In this
way, it is possible to reduce the risk of treating an ovarian cancer during
laparoscopy.1,3,35
Canis et al.6 compared the accuracy of laparoscopic diagnosis with that of histo-
diagnosis in 819 adnexal masses. They found that all the malignant tumors that had
been considered cancerous or suspicious at laparoscopy were confirmed histologi-
cally (sensitivity 100%). The positive predictive value was 41.3%, and the negative
predictive value was 100%.
During laparoscopy, we can also study the ovarian cyst by laparoscopic ultra-
sound imaging (LUI). LUI is performed by using a high-frequency, multiple focus
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transducer (7.5 MHz): sector, convex, or linear. The possibility of having real-time
multiplane imaging of the organs increases the accuracy of diagnosis.
The transducer (UST-5521, Aloka, Japan) is a 7.5-MHz linear array designed
for easy insertion through a 10-mm trocar; it is applicable to SSD 620 (Aloka, Ja-
pan) ultrasound equipment and can be used to perform intraoperative ultrasound
examinations.
The closeness of the LUI probe to the ovary, the use of a high-frequency trans-
ducer with high resolution, and the possibility of using color Doppler are among the
advantages of this technique. It is even possible to identify very small papillary for-
mations on the internal wall of the cysts. Identification of these formations is not
possible when using conventional abdominal ultrasonography: it is difficult even
when using transvaginal ultrasonography.
After using this imaging approach, our preliminary evaluation of LUI is that this
type of ultrasonography can be a reliable diagnostic tool during gynecological oper-
ative endoscopy. It can also be helpful in intraoperative decision-making.36
An ovarian cyst may be sometimes histopathologically diagnosed as being a car-
cinoma of low malignant potential or a borderline ovarian tumor. Unilateral salpin-
go-oophorectomy, or, in some cases, cystectomy, is a valid alternative treatment in
young women with localized (stage IA) disease.37 These borderline tumors present
a high survival rate (93%) at five years. A study of 254 cases was carried out by Man-
gioni et al.,38 and they reported that not one of these patients had died because of the
malignancy. Conservative surgery is a valid alternative in those patients still at re-
productive age. Pelvic and para-aortic lymphadenectomy are indicated in stage III
subjects with peritoneal spread: laparoscopic follow-up is suggested. However, even
if no specific sonographic aspect exists for the identification of borderline tumors,
ultrasonography is the best way to detect their recurrence. Conservative treatment of
borderline ovarian tumors includes a laparoscopic procedure. Even if there appears
to be a high risk of intraoperative rupture, the rate of recurrence is similar to that of
laparotomic treatment.39 Available data indicate that fertility, pregnancy outcome,
and survival in such patients remain excellent.40
In 1993, the Italian Society of Endoscopy and Laser Therapy in Gynecology
(S.I.E.L.G.) decided to perform a multicenter prospective study. The aim of the study
was to verify whether laparoscopic treatment of ovarian cysts could be reliable and
safe even in women over 40, when cautious management and strict guidelines were
used. Forty-seven Italian Centers of Gynecological Endoscopy participated (from
June 1994 until December 1995). The safety of laparoscopic treatment in women
over 40 with ovarian persistent cysts was evaluated. Four hundred and six patients
over 40 years of age (37.2% in postmenopause) took part in the study. All patients
were divided into two groups according to the ultrasonographic characteristics of the
cysts (benign or suspect). A comparison was made between 289 patients with benign
ultrasonographic findings (group A) and 117 patients of the same age with ultra-
sonographic criteria that included septa, vegetation, solid components, or complex
masses (group B).
The average age of group A subjects was 51.4 ± 8. Age ranged from 40 to 78
years. Histological diagnosis of the 289 ultrasonically identified benign cysts con-
firmed that they were all nonmalignant. In the 117 patients with suspicious ultra-
sonographic criteria (group B), four cases of malignancy were found: two were cases
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of serous cystoadenocarcinoma, one was a moderately differentiated Leydig cell tu-
mor, and one was a low-malignant-potential tumor.
Statistical elaboration was carried out using the χ2 method. Considering the prev-
alence of carcinoma in relation to the ultrasonographic findings, there was a signif-
icant statistical difference between the two groups (p = 0.009). Moreover, in the
patients with no benign ultrasonographic criteria, there were no significant statistical
differences between those in premenopause and those in postmenopause (p = 0.612).
At our department we treated a series of 276 ovarian cysts using laparoscopy. Six-
ty-eight patients were over 40 years of age. In 15 of the 68 cases (22%), the serum
levels of the tumoral ovarian markers were abnormal. The ovarian markers were ab-
normal in endometriotic cysts and in dermoid cysts, as well as in paraovarian and in
simple serous cysts. The diameters of all the cysts were 43 ± 13 mm (range 5–80).
The duration of surgery was 59 ± 26 min (range: 15–120 min.). In two cases where
severe adhesion was present, two laparoscopic (0.7%) procedures were converted
into laparotomies. The duration of hospital stay was 2.6 ± 1.3 days. No relapses were
noted at follow-up in the ultrasonographic controls. In this series we performed ex-
cision of the cyst in 45% of the cases and an adnexectomy in 55% of the cases. We
did not find any case of malignancy.
In conclusion, operative laparoscopy represents a valid alternative for the treat-
ment of benign adnexal masses, even in women over 40. The majority of cysts in this
age group of women are benign. Patient selection for laparoscopic surgery is very
important. Patient selection should be based on transvaginal ultrasound, color Dop-
pler, dosage of CA125, clinical examination, and case history. This multimodal ap-
proach is fundamental for avoiding treatment of malignant masses. If the benign
ultrasonographic criteria, (unilateral mass, unilocular cysts, absence of septa >3 mm
and intracystic vegetations, defined borders) are respected and the serum level of
CA125 is <35 IU/ml, the probability of the presence of a benign cyst is very high.
Furthermore, during laparoscopy, we can obtain information from the cyst itself and
from the peritoneal cavity. Endoscopic bags can be used to remove the cyst or the
whole ovary without any spillage. Thus, intraoperative histological examination can
be carried out. In this way, it is possible to reduce the risk of treating an ovarian can-
cer at laparoscopy.
Laparoscopic treatment of ovarian masses can be considered useful and safe,
even in post-menopausal patients. However, the following criteria must be met: be-
nign sonographic aspects, CA125 <35 IU/ml, and benign laparoscopic features. On
the other hand, if vegetation, septa, and/or solid or complex cysts are present, there
is no diagnostic possibility of eliminating the risk of finding and treating ovarian ma-
lignant masses. Ultrasonography is perhaps the most important tool available for dis-
tinguishing benign from malignant adnexal masses.
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